Records containing: Postoperative Nausea and Vomiting
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2018-02-13Effect of Intravenous Versus Intra-peritoneal Dexamethasone on the Incidence of Postoperative Nausea and Vomiting Following Laparoscopic Gynecological Surgeries
-
CLINICAL_TRIALS study record update · 2018-01-23Influence of Surgical Pleth Index-guided Analgesia Using Different Techniques on the Perioperative Outcomes in Patients Undergoing Vitreoretinal Surgery Under General Anaesthesia: Randomised, Controlled Trial
-
CLINICAL_TRIALS study record update · 2017-11-21A Prospective Randomize Study: Prevention of Nausea and Vomiting in Plastic Surgery
-
CLINICAL_TRIALS study record update · 2017-10-27ClinicalTrials.gov study NCT02480088
-
CLINICAL_TRIALS study record update · 2017-08-11A Prospective Randomized Evaluation of an Intraoperative Electronic Reminder Module to Enhance Postoperative Nausea and Vomiting Prophylaxis Guideline Adherence
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-08-09Prophylactic Antiemetic Efficacy of Palonosetron Versus Ondansetron for the Prophylaxis of Postoperative Nausea and Vomiting (PONV) in Women Over 60 Years Undergoing Laparoscopic Cholecystectomy
-
CLINICAL_TRIALS study record update · 2017-07-25Dexamethasone as an Analgesic Adjunct for Post-cesarean Delivery Pain Relief
-
CLINICAL_TRIALS study record update · 2017-06-28Prophylaxy of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Surgery
-
CLINICAL_TRIALS study record update · 2017-06-06Risk Factors for Nausea, Vomiting and Pruritus After Neuraxial Morphine for Cesarean Section
-
CLINICAL_TRIALS study record update · 2017-05-11Gabapentin Premedication to Reduce Postoperative Nausea and Vomiting in Surgical Patient Receiving Spinal Morphine
-
CLINICAL_TRIALS study record update · 2017-05-08Intraoperative Intravenous Dextrose Administration and the Incidence of Nausea and Vomiting After the Gynecologic Laparoscopic Surgery A Randomized Double-Blinded Controlled Study
-
CLINICAL_TRIALS study record update · 2017-05-05A Randomized, Double-Blind, Active Comparator-Controlled, Parallel-Group Study, Conducted Under In-House Blinding Conditions, to Examine the Safety, Tolerability, and Efficacy of 2 Doses of Aprepitant for the Prevention of Postoperative Nausea and Vomiting
-
CLINICAL_TRIALS study record update · 2017-05-05Studying the Effectiveness of Triple Therapy With Palonosetron, Dexamethasone and Promethazine for Prevention of Post Operative Nausea and Vomiting in High Risk Patients Undergoing Neurological Surgery and General Anesthesia
-
CLINICAL_TRIALS study record update · 2017-05-05A Randomized, Double-Blind, Active Comparator-Controlled, Parallel-Group Study, Conducted Under In-House Blinding Conditions, to Examine the Safety, Tolerability, and Efficacy of 2 Doses of Aprepitant for the Prevention of Postoperative Nausea and Vomiting
-
CLINICAL_TRIALS study record update · 2017-04-25Postoperative Nausea and Vomiting: Ramosetron Plus Aprepitant vs Palonosetron Plus Aprepitant
-
CLINICAL_TRIALS study record update · 2017-04-12A Prospective, Randomized, Double-Blinded Study to Evaluate the Efficacy of Intravenous Dexamethasone for Nausea Prophylaxis Prior to Duramorph and Bupivacaine Spinal Anesthesia for Scheduled Cesarean Section
-
CLINICAL_TRIALS study record update · 2017-03-29A Randomized Blinded Pilot Study to Compare Targinact vs. Oxycodone in Early Return of Gastrointestinal Function After Colorectal Surgery
-
CLINICAL_TRIALS study record update · 2017-03-23A Phase III Multicenter, Randomized, Double-blind, Parallel Group Study to Evaluate the Safety and Efficacy of the 30 mg Intravenous Formulation of the Neurokinin-1 Receptor Antagonist GW679769 for Prevention of Postoperative Nausea and Vomiting in Female Subjects at High Risk for Emesis
-
CLINICAL_TRIALS study record update · 2017-03-06Effects of Low Doses of Ketamine on Postoperative Quality of Recovery After Total Intravenous Anesthesia
-
CLINICAL_TRIALS study record update · 2017-03-03Risk Factors for Postoperative Nausea/Vomiting After Implementation of Prophylaxis Guideline for High Risk Patients
-
CLINICAL_TRIALS study record update · 2017-02-07A Prospective, Randomized, Double-blind, Placebo-controlled Study of Caffeine in the Prevention of Post-operative Nausea and Vomiting in Patients Undergoing Ambulatory Surgery Under General Anesthesia
-
CLINICAL_TRIALS study record update · 2017-01-25ClinicalTrials.gov study NCT02478645
-
CLINICAL_TRIALS study record update · 2017-01-20A Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging, Parallel Group Phase II Study to Evaluate the Safety, Efficacy and Pharmacokinetics of the Oral Neurokinin-1 Receptor Antagonist, GW679769, When Administered With Intravenous Ondansetron Hydrochloride for the Prevention of Post-operative Nausea and Vomiting (PONV) and Post-discharge Nausea and Vomiting (PDNV) in Female Subjects With Known Risk Factors for PONV Who Are Undergoing Surgical Procedures Associated With an Increased Emetogenic Risk
-
CLINICAL_TRIALS study record update · 2017-01-20Phase II Multicenter, Dose Ranging Study on the Safety and Antiemetic Efficacy of One Day Intraveous Dosing of GW597599 Administered With Ondansetron HCL in a Female Subjects Undergoing Surgical Procedures of High Emetogenic Risk
-
CLINICAL_TRIALS study record update · 2017-01-20A Multicenter, Randomised, Double-blind, Placebo-controlled, Parallel Group, Phase II Study to Evaluate the Safety and Efficacy of Oral Dosing With GW679769 (50 mg or 150 mg) for Three Consecutive Days When Administered With a Single Intravenous Dose of Ondansetron Hydrochloride for the Prevention of Post-operative Nausea and Vomiting and Post-discharge Nausea and Vomiting in Female Subjects With Known Risk Factors for Post-operative Nausea and Vomiting Who Are Undergoing Laparoscopic/Laparotomic Surgical Procedures Associated With an Increased Emetogenic Risk